ArticleJournal of neurology2022

Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study.

Maria Pia Giannoccaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.